Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

Analysts Are Downgrading These 10 Stocks

In this article, we will discuss the 10 stocks recently downgraded by analysts. If you want to see more such stocks on the list, you can directly visit Analysts Are Downgrading These 5 Stocks.

Caterpillar Inc. (NYSE:CAT), Emerson Electric Co. (NYSE:EMR), Marriott International, Inc. (NASDAQ:MAR) and CF Industries Holdings, Inc. (NYSE:CF) were among the notable stocks that were recently downgraded by analysts.

Emerson Electric Co. (NYSE:EMR) was downgraded amid near-term headwinds and the latest earnings miss, while ratings for CF Industries Holdings, Inc. (NYSE:CF) were cut amid dropping urea prices. Check out the complete article to see the details of these downgrades.

Photo by Ruben Sukatendel on Unsplash

10. Upstart Holdings, Inc. (NASDAQ:UPST)

Number of Hedge Fund Holders: 20

Citi downgraded Upstart Holdings, Inc. (NASDAQ:UPST) from “Neutral” to “Sell” on Wednesday, February 15. The research firm pointed towards the tightening financial environment and how it could make it difficult for Upstart to secure funding for its lending platform.

The rating cut came a day after the company’s Q4 results. Upstart Holdings, Inc. (NASDAQ:UPST) on Tuesday reported better-than-expected quarterly results but its sales outlook for the current quarter missed expectations.

For the fourth quarter, Upstart Holdings, Inc. (NASDAQ:UPST) reported a loss of 25 cents per share, narrower than the consensus forecast calling for a loss of 47 cents. In addition, revenue for the quarter plummeted 52 percent versus last year to $147 million but came in above the expectations of $133.59 million.

For the first quarter, Upstart Holdings, Inc. (NASDAQ:UPST) projected revenue of approx. $100 million, significantly below analysts’ average estimate of $157.99 million. Nevertheless, Upstart shares climbed nearly 28 percent on February 15 despite offering weak guidance.

9. Globus Medical, Inc. (NYSE:GMED)

Number of Hedge Fund Holders: 20

BofA recently turned bearish on Globus Medical, Inc. (NYSE:GMED), citing its decision to acquire NuVasive. Analyst Craig Bijou lowered his ratings for the medical device company from “Buy” to “Underperform” on Monday, February 13

Bijou sees risk to revenue estimates amid possible dis-synergies. The analyst also cut his price target for Globus Medical, Inc. (NYSE:GMED) from $83 per share for $63 per share.

Globus Medical, Inc. (NYSE:GMED) last week decided to buy NuVasive in an all-stock transaction valued at roughly $3 billion. The company plans to strengthen its foothold in the spinal devices market with the acquisition.

8. Akamai Technologies, Inc. (NASDAQ:AKAM)

Number of Hedge Fund Holders: 32

RBC Capital lowered its ratings for Akamai Technologies, Inc. (NASDAQ:AKAM) from “Outperform” to “Sector Perform” on Wednesday, February 15. Analyst Rishi Jaluria was mainly moved by the company’s strategic shift towards cloud computing.

Jaluria thinks the evident change in strategy alters the risk-reward profile of Akamai Technologies, Inc. (NASDAQ:AKAM). The analyst also lowered his price target for AKAM stock from $100 per share to $85 per share.

Akamai Technologies, Inc. (NASDAQ:AKAM) recently posted its Q4 results, surpassing expectations for both profit and sales. However, investors seemed disappointed with the company’s changing business priorities.

The company’s senior management intends to expand its cloud business. However, Akamai Technologies, Inc. (NASDAQ:AKAM) would need to spend a lot of capital to strengthen its cloud arm.

7. Lyft, Inc. (NASDAQ:LYFT)

Number of Hedge Fund Holders: 37

Argus downgraded Lyft, Inc. (NASDAQ:LYFT) from “Buy” to “Hold” on Tuesday, February 14. Analyst Bill Selesky was primarily moved by the company’s Q4 operating loss and soft sales outlook.

Lyft, Inc. (NASDAQ:LYFT) shares lost nearly 40 percent of their value on Friday, February 10, following its mixed earnings and outlook. The ride-hailing service reported a negative adjusted Ebitda of $248.3 million for the fourth quarter. On the bright side, the quarterly revenue of $1.2 billion was above the consensus of $1.16 billion.

However, its sales outlook for the current quarter was below the consensus. Lyft, Inc. (NASDAQ:LYFT) projected revenue of around $975 million for the current quarter, below analysts’ average estimate of $1.09 billion.

Like Lyft, Inc. (NASDAQ:LYFT), analysts also recently trimmed their ratings for Caterpillar Inc. (NYSE:CAT), Emerson Electric Co. (NYSE:EMR) and CF Industries Holdings, Inc. (NYSE:CF).

6. XPO, Inc. (NYSE:XPO)

Number of Hedge Fund Holders: 37

Several research firms cut their ratings for XPO, Inc. (NYSE:XPO) after its recent earnings. Evercore ISI downgraded the transportation company from “Outperform” to “In-Line” on Tuesday, February 14, citing macro hurdles and elevated corporate costs.

Separately, Morgan Stanley slashed its ratings for XPO, Inc. (NYSE:XPO) from “Overweight” to “Equal-Weight” on Monday, February 13, stating that the market is looking for more clarity around the company’s long-term goals. The research firm also cut its price target for XPO stock from $55 per share to $43 per share.

The downgrades follow the company’s Q4 results. XPO, Inc. (NYSE:XPO) recently reported adjusted earnings of 98 cents per share on sales of $1.8 billion for the fourth quarter. Analysts were looking for earnings of 83 cents per share on revenue of $1.8 billion.

Click to continue reading and see Analysts Are Downgrading These 5 Stocks.

Suggested articles:

Disclosure: None. Analysts Are Downgrading These 10 Stocks is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.